[Polychemotherapy of multiple myeloma using pafencil (COPPaf protocol)].
Tsykalov
V A
VA
Zhuravlev
V S
VS
Mokeeva
R A
RA
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D011344:Procarbazine / Q000008:administration & dosage / Q000009:adverse effects; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
D009588:Nitrogen Mustard Compounds; D011344:Procarbazine; C031372:pafencil; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone
Polikhimioterapiia mnozhestvennoĭ mielomy s ispol'zovniem pafentsila (skhema COPPaf).